ImmunoScape Advances Seed And Boost Cancer Therapy Programme With United States Clinical Collaboration

The company also announced a strategic investment from Leonardo DiCaprio ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures an...

March 06, 2026 | Friday | News
Allosteric Bioscience Advances Integrated Platform To Decode And Control Molecular Drivers Of Aging

Allosteric Bioscience, Inc. is utilizing Genetics, Genomics, Systems Biology, Quantum Computing, Advanced Proprietary AI and Proprietary Molecular ...

March 06, 2026 | Friday | News
Former BioDuro Leadership Launches Forma Life Sciences as Independent CDMO

-Forma Life Sciences, Inc. announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on o...

March 05, 2026 | Thursday | News
Forge Biologics to Manufacture PRF’s SamPro-2 Gene Therapy for IND Advancement

The Progeria Research Foundation (“PRF”), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gi...

March 05, 2026 | Thursday | News
MGI Becomes First to Unite Short-Read, Long-Read, and Spatial Omics Under One Platform

MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, announced the acqui...

March 05, 2026 | Thursday | News
FUJIFILM Biotechnologies Launches ShunzymeX™ to Transform Microbial Downstream Processing

FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, &nb...

March 05, 2026 | Thursday | News
Cure Rare Disease and LGMD2L Foundation Launch $7.65M Partnership to Advance ANO5 Gene Therapy

  Cure Rare Disease (CRD), a non-profit biotechnology organization, announced a landmark partnership with the LGMD2L Foundation. This collaboration i...

March 04, 2026 | Wednesday | News
Human-Centric AI: Accelerating Formulation Development Without Compromising Trust

As artificial intelligence becomes increasingly embedded in formulation science and early clinical planning, the industry faces a dual challenge: accelerat...

March 04, 2026 | Wednesday | Expert Opinion
Antengene Corporation Limited Secures South Korea NHIS Reimbursement for XPOVIO® in Multiple Myeloma

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult...

March 03, 2026 | Tuesday | News
Biocytogen Secures $5 Million Milestone as IDEAYA Doses First Patient in Phase 1 Trial of Bispecific ADC IDE034

IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as mono...

March 02, 2026 | Monday | News
Fangzhou and Youcare Forge Strategic AI Partnership to Advance Digital Chronic Disease Management in China

Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has sig...

March 02, 2026 | Monday | News
Designing Decarbonization: Embedding Sustainability at the Core of Life Sciences Infrastructure

As life sciences companies scale biologics, advanced therapies, and personalized medicines, sustainability has moved from aspiration to operational imperat...

March 02, 2026 | Monday | News
GSK Expands Immunology Pipeline Through siRNA Licensing Agreement with Frontier Biotech

Frontier Biotechnologies Inc. (hereinafter referred to as "Frontier Biotech" or "the Company") has entered into an exclusive licensing agreemen...

February 26, 2026 | Thursday | News
PacBio and DNAstack Unite to Accelerate Rare Disease Discovery Through Federated HiFi Sequencing

PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies,  announced a collaboration with DNAstack to power the wor...

February 26, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close